Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
24.14
+0.34 (1.43%)
At close: Jul 16, 2025, 4:00 PM
24.14
0.00 (0.00%)
After-hours: Jul 16, 2025, 4:00 PM EDT
Nektar Therapeutics Employees
Nektar Therapeutics had 61 employees as of December 31, 2024. The number of employees decreased by 76 or -55.47% compared to the previous year.
Employees
61
Change (1Y)
-76
Growth (1Y)
-55.47%
Revenue / Employee
$1,430,295
Profits / Employee
-$2,181,000
Market Cap
419.03M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
NKTR News
- 14 days ago - Nektar Therapeutics Announces Closing of $115 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares - PRNewsWire
- 15 days ago - Nektar Therapeutics Announces Pricing of $100 Million Public Offering - PRNewsWire
- 16 days ago - Nektar Therapeutics Announces Proposed Public Offering - PRNewsWire
- 19 days ago - Nektar Therapeutics Scores Big Phase 2b Win With Rezpeg - Seeking Alpha
- 21 days ago - Why Is Nektar Therapeutics Stock Trading Higher On Wednesday? - Benzinga
- 22 days ago - Nektar Therapeutics Is Up 150%: What's Happening With NKTR Stock? - Forbes
- 22 days ago - Nektar Therapeutics' experimental eczema drug meets main goals of mid-stage trial - Reuters
- 22 days ago - REZOLVE-AD Phase 2b Study of Rezpegaldesleukin Meets Primary and Key Secondary Endpoints in Patients with Moderate-to-Severe Atopic Dermatitis - PRNewsWire